LINDSEY EATON: Open Payments
NPI 1679070601 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$988 in 9 payments from 7 companies in 2025. Trend: 2023 $170 · 2024 $276 · 2025 $988
Food & beverage: $988
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $293 |
| JAZZ PHARMACEUTICALS INC. | 1 | $150 |
| Caris MPI, Inc. | 1 | $137 |
| AstraZeneca Pharmaceuticals LP | 1 | $135 |
| Gilead Sciences, Inc. | 1 | $135 |
| Sumitomo Pharma America, Inc. | 2 | $108 |
| Amgen Inc. | 1 | $31 |
Products named: RYBREVANT, ZIIHERA, MI CANCER SEEK, ORGOVYX, BLINCYTO.
Industry payments across WA — which companies pay providers there.
